Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases

Por Sautto, Giuseppe A., Diotti, Roberta A.
Publicado no Front Immunol (2020)

New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases

Por Sautto, Giuseppe A., Diotti, Roberta A., Wisskirchen, Karin, Kahle, Kristen M.
Publicado no J Immunol Res (2017)

HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role

Por Sautto, Giuseppe, Mancini, Nicasio, Solforosi, Laura, Diotti, Roberta A., Clementi, Massimo, Burioni, Roberto
Publicado em 2012

Next Generation Vaccines for Infectious Diseases

Por Sautto, Giuseppe A., Kirchenbaum, Greg A., Diotti, Roberta A., Criscuolo, Elena, Ferrara, Francesca
Publicado no J Immunol Res (2019)

Neutralization Interfering Antibodies: A “Novel” Example of Humoral Immune Dysfunction Facilitating Viral Escape?

Por Nicasio, Mancini, Sautto, Giuseppe, Clementi, Nicola, Diotti, Roberta A., Criscuolo, Elena, Castelli, Matteo, Solforosi, Laura, Clementi, Massimo, Burioni, Roberto
Publicado em 2012

Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects

Por Criscuolo, Elena, Castelli, Matteo, Diotti, Roberta A., Amato, Virginia, Burioni, Roberto, Clementi, Massimo, Ambrosi, Alessandro, Mancini, Nicasio, Clementi, Nicola
Publicado no J Virol (2019)

Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials

Por Criscuolo, Elena, Diotti, Roberta A., Ferrarese, Roberto, Alippi, Cesare, Viscardi, Gabriele, Signorelli, Carlo, Mancini, Nicasio, Clementi, Massimo, Clementi, Nicola
Publicado no Emerg Microbes Infect (2021)

Weak correlation between antibody titers and neutralizing activity in sera from SARS‐CoV‐2 infected subjects

Por Criscuolo, Elena, Diotti, Roberta A., Strollo, Marta, Rolla, Serena, Ambrosi, Alessandro, Locatelli, Massimo, Burioni, Roberto, Mancini, Nicasio, Clementi, Massimo, Clementi, Nicola
Publicado no J Med Virol (2020)

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein

Por Sautto, Giuseppe A, Wisskirchen, Karin, Clementi, Nicola, Castelli, Matteo, Diotti, Roberta A, Graf, Julia, Clementi, Massimo, Burioni, Roberto, Protzer, Ulrike, Mancini, Nicasio
Publicado no Gut (2016)

Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

Por Mancini, Nicasio, Diotti, Roberta A., Perotti, Mario, Sautto, Giuseppe, Clementi, Nicola, Nitti, Giovanni, Patel, Arvind H., Ball, Jonathan K., Clementi, Massimo, Burioni, Roberto
Publicado em 2009

Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein

Por Perotti, Mario, Mancini, Nicasio, Diotti, Roberta A., Tarr, Alexander W., Ball, Jonathan K., Owsianka, Ania, Adair, R., Patel, Arvind H., Clementi, Massimo, Burioni, Roberto
Publicado em 2008

A Biologically-validated HCV E1E2 Heterodimer Structural Model

Por Castelli, Matteo, Clementi, Nicola, Pfaff, Jennifer, Sautto, Giuseppe A., Diotti, Roberta A., Burioni, Roberto, Doranz, Benjamin J., Dal Peraro, Matteo, Clementi, Massimo, Mancini, Nicasio
Publicado no Sci Rep (2017)